PL372290A1 - Farmaceutyczna postać dawkowana do podawania śluzówkowego - Google Patents
Farmaceutyczna postać dawkowana do podawania śluzówkowegoInfo
- Publication number
- PL372290A1 PL372290A1 PL03372290A PL37229003A PL372290A1 PL 372290 A1 PL372290 A1 PL 372290A1 PL 03372290 A PL03372290 A PL 03372290A PL 37229003 A PL37229003 A PL 37229003A PL 372290 A1 PL372290 A1 PL 372290A1
- Authority
- PL
- Poland
- Prior art keywords
- dosage form
- pharmaceutical dosage
- mucosal delivery
- tablet
- subject
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35570302P | 2002-02-07 | 2002-02-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL372290A1 true PL372290A1 (pl) | 2005-07-11 |
Family
ID=27734551
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL03372290A PL372290A1 (pl) | 2002-02-07 | 2003-02-06 | Farmaceutyczna postać dawkowana do podawania śluzówkowego |
Country Status (21)
Country | Link |
---|---|
US (1) | US20030235617A1 (pl) |
EP (1) | EP1471890B1 (pl) |
JP (1) | JP2005519924A (pl) |
KR (1) | KR100666520B1 (pl) |
CN (1) | CN100346832C (pl) |
AT (1) | ATE340565T1 (pl) |
AU (1) | AU2003215110B2 (pl) |
BR (1) | BR0307473A (pl) |
CA (1) | CA2474190A1 (pl) |
CO (1) | CO5611096A2 (pl) |
DE (1) | DE60308647T2 (pl) |
DK (1) | DK1471890T3 (pl) |
ES (1) | ES2271542T3 (pl) |
MX (1) | MXPA04007728A (pl) |
NO (1) | NO20043723L (pl) |
NZ (1) | NZ534340A (pl) |
PL (1) | PL372290A1 (pl) |
PT (1) | PT1471890E (pl) |
RU (1) | RU2285520C2 (pl) |
WO (1) | WO2003066029A2 (pl) |
ZA (1) | ZA200405614B (pl) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040202717A1 (en) | 2003-04-08 | 2004-10-14 | Mehta Atul M. | Abuse-resistant oral dosage forms and method of use thereof |
BRPI0302736B8 (pt) * | 2003-06-02 | 2021-05-25 | Ems S/A | composição farmacêutica a base de cetorolaco ou de um de seus sais farmaceuticamente aceitáveis para uso sublingual |
SE0401031D0 (sv) * | 2004-04-22 | 2004-04-22 | Duocort Ab | A new glucocorticoid replacement therapy |
JP5004236B2 (ja) * | 2005-02-09 | 2012-08-22 | キッセイ薬品工業株式会社 | 口腔内崩壊錠 |
US8744546B2 (en) | 2005-05-05 | 2014-06-03 | Dexcom, Inc. | Cellulosic-based resistance domain for an analyte sensor |
CN101495080B (zh) * | 2006-01-06 | 2013-10-23 | 阿塞尔Rx制药有限公司 | 药物存储及发放装置以及包括该装置的*** |
US20110318412A1 (en) * | 2006-05-19 | 2011-12-29 | Somaxon Pharmaceuticals, Inc. | Low dose doxepin formulations, including buccal, sublingual and fastmelt formulations, and uses of the same to treat insomnia |
US20090042972A1 (en) * | 2006-05-19 | 2009-02-12 | Somaxon Pharmaceuticals, Inc. | Methods of using low-dose doxepin for the improvement of sleep |
US20090042971A1 (en) * | 2006-05-19 | 2009-02-12 | Somaxon Pharmaceuticals, Inc. | Method of using low-dose doxepin for the improvement of sleep |
US20080058408A1 (en) * | 2006-05-19 | 2008-03-06 | Rogowski Roberta L | Low-dose doxepin for treatment of sleep disorders in elderly patients |
US8513299B2 (en) | 2006-05-19 | 2013-08-20 | Pernix Sleep, Inc. | Methods of using low-dose doxepin for the improvement of sleep |
US20100179215A1 (en) | 2006-05-19 | 2010-07-15 | Somaxon Pharmaceuticals, Inc. | Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders |
US20100179214A1 (en) | 2006-05-19 | 2010-07-15 | Somaxon Pharmaceuticals, Inc. | Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders |
US20100227916A1 (en) * | 2006-05-19 | 2010-09-09 | Somaxon Pharmaceuticals, Inc | N-desmethyl-doxepin and methods of using the same to treat sleep disorders |
DE102006027796A1 (de) * | 2006-06-16 | 2007-12-20 | Lts Lohmann Therapie-Systeme Ag | Estrogen-Gestagen-Kombinationen |
BRPI0621852A2 (pt) * | 2006-07-07 | 2011-12-20 | Teva Pharma | compostos sólidos consistindo de tadalafil e pelo menos um veìculo |
WO2008011150A1 (en) * | 2006-07-20 | 2008-01-24 | Somaxon Pharmaceuticals, Inc. | Methods of improving the pharmacokinetics of doxepin |
WO2008085567A1 (en) * | 2006-10-04 | 2008-07-17 | Somaxon Pharmaceuticals, Inc. | Methods of using low-dose doxepin for the improvement of sleep |
WO2008052139A2 (en) | 2006-10-25 | 2008-05-02 | Somaxon Pharmaceuticals, Inc. | Ultra low dose doxepin and methods of using the same to treat sleep disorders |
US20110077200A1 (en) * | 2006-12-06 | 2011-03-31 | Somaxon Pharmaceuticals, Inc. | Combination therapy using low-dose doxepin for the improvement of sleep |
CA2721133C (en) | 2007-04-13 | 2018-11-06 | Somaxon Pharmaceuticals, Inc. | Low-dose doxepin formulations and methods of making and using the same |
JP2010525082A (ja) * | 2007-04-25 | 2010-07-22 | テバ ファーマシューティカル インダストリーズ リミティド | 固体投与形 |
DE102007028869A1 (de) * | 2007-06-22 | 2008-12-24 | Ratiopharm Gmbh | Verfahren zur Herstellung eines Arzneimittels enthaltend Tadalafil |
US20090036414A1 (en) * | 2007-08-02 | 2009-02-05 | Mutual Pharmaceutical Company, Inc. | Mesalamine Formulations |
CN102395270B (zh) * | 2008-07-07 | 2014-11-12 | 法斯根公司 | 化合物、含有其的药物组合物、其使用方法及其制备方法 |
CN101757623B (zh) * | 2008-10-09 | 2013-12-04 | 北京德众万全药物技术开发有限公司 | 一种5-ht受体激动剂固体药物组合物 |
TWI455733B (zh) | 2009-03-30 | 2014-10-11 | Toray Industries | 口腔內崩壞性被覆錠劑 |
US20110268809A1 (en) | 2010-04-28 | 2011-11-03 | Paul Andrew Brinkley | Nicotine-Containing Pharmaceutical Compositions |
US20110274628A1 (en) | 2010-05-07 | 2011-11-10 | Borschke August J | Nicotine-containing pharmaceutical compositions |
EA015250B9 (ru) * | 2010-11-19 | 2013-10-30 | Тева Фармасьютикал Индастриз, Лтд. | Таблетка силденафила, обеспечивающая модифицированную фармакокинетику, и способ ее изготовления |
US20120195954A1 (en) * | 2011-02-02 | 2012-08-02 | Roxiticus Health Products, Llc | Method of Reducing Appetite |
US9629392B2 (en) | 2011-09-22 | 2017-04-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9474303B2 (en) | 2011-09-22 | 2016-10-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US20130078307A1 (en) | 2011-09-22 | 2013-03-28 | Niconovum Usa, Inc. | Nicotine-containing pharmaceutical composition |
US9084439B2 (en) | 2011-09-22 | 2015-07-21 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9907748B2 (en) | 2011-10-21 | 2018-03-06 | Niconovum Usa, Inc. | Excipients for nicotine-containing therapeutic compositions |
US9763928B2 (en) | 2012-02-10 | 2017-09-19 | Niconovum Usa, Inc. | Multi-layer nicotine-containing pharmaceutical composition |
EP2844234B1 (de) * | 2012-04-27 | 2020-01-08 | Merck Patent GmbH | Tabletten mit überzug und deren herstellung |
PT3417862T (pt) * | 2012-07-27 | 2021-08-06 | Neurodyn Life Sciences Inc | Biodisponibilidade cerebral da galantamina melhorada através de formulações selecionadas e administração transmucosal de pró-fármacos lipofílicos |
US20140255452A1 (en) | 2013-03-11 | 2014-09-11 | Niconovum Usa, Inc. | Method and apparatus for differentiating oral pouch products |
WO2015023675A2 (en) | 2013-08-12 | 2015-02-19 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US10172797B2 (en) | 2013-12-17 | 2019-01-08 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
EP3106152B1 (en) | 2014-02-12 | 2021-02-17 | Sawai Pharmaceutical Co., Ltd. | Orally disintegrating tablet coated with film |
US9561233B2 (en) | 2014-03-13 | 2017-02-07 | Demerx, Inc. | Use of ibogaine for the treatment of pain |
AU2015290098B2 (en) | 2014-07-17 | 2018-11-01 | Pharmaceutical Manufacturing Research Services, Inc. | Immediate release abuse deterrent liquid fill dosage form |
US9592239B2 (en) | 2014-09-12 | 2017-03-14 | Demerx, Inc. | Methods and compositions for ibogaine treatment of impulse control disorder, anxiety-related disorders, violence and/or anger, or regulating food intake |
EP3209282A4 (en) | 2014-10-20 | 2018-05-23 | Pharmaceutical Manufacturing Research Services, Inc. | Extended release abuse deterrent liquid fill dosage form |
JP6529822B2 (ja) * | 2015-05-22 | 2019-06-12 | 東和薬品株式会社 | トリプタン系化合物を含有する口腔内崩壊錠 |
US20170165252A1 (en) | 2015-12-10 | 2017-06-15 | Niconovum Usa Inc. | Protein-enriched therapeutic composition |
RU2649834C1 (ru) * | 2016-07-06 | 2018-04-04 | Фармалидер С.А. | Фармацевтическая композиция силденафила цитрата в форме суспензии для перорального применения |
GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
WO2019239356A1 (en) | 2018-06-15 | 2019-12-19 | R. J. Reynolds Tobacco Company | Purification of nicotine |
CN113613630A (zh) | 2019-03-01 | 2021-11-05 | 因斯格尼斯疗法有限公司 | 地匹福林口腔崩解片剂制剂 |
JP2022529781A (ja) | 2019-04-17 | 2022-06-24 | コンパス パスファインダー リミテッド | サイロシビンによるうつ病及び他の様々な障害の治療 |
CN111499545B (zh) * | 2020-04-27 | 2022-05-03 | 武汉英纳氏药业有限公司 | 一种对氨基取代苯酚类化合物的制备方法 |
JP2023553300A (ja) | 2020-11-25 | 2023-12-21 | インターベット インターナショナル ベー. フェー. | フルニキシンを口腔投与することによる疼痛の治療方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0181966A1 (en) * | 1984-11-13 | 1986-05-28 | Gist-Brocades N.V. | Compression-coated dispersible tablets |
US5273975A (en) * | 1989-06-09 | 1993-12-28 | The Upjohn Company | Heterocyclic amines having central nervous system activity |
CA2181990C (en) * | 1994-01-27 | 2000-09-26 | Loyd V. Allen, Jr. | Rapidly dissolving oral dosage form |
US6121276A (en) * | 1994-04-22 | 2000-09-19 | Pentech Pharmaceuticals, Inc. | Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
CA2188385C (en) * | 1994-04-22 | 2000-07-11 | Ragab El-Rashidy | Dosage forms and method for ameliorating male erectile dysfunction |
US5888534A (en) * | 1995-06-13 | 1999-03-30 | Pentech Pharmaceuticals, Inc. | Controlled release of drugs delivered by sublingual or buccal administration |
US5624677A (en) * | 1995-06-13 | 1997-04-29 | Pentech Pharmaceuticals, Inc. | Controlled release of drugs delivered by sublingual or buccal administration |
GB9616672D0 (en) * | 1996-08-08 | 1996-09-25 | Scherer Ltd R P | Pharmaceutical compositions |
US5939091A (en) * | 1997-05-20 | 1999-08-17 | Warner Lambert Company | Method for making fast-melt tablets |
WO1999022769A1 (en) * | 1997-10-31 | 1999-05-14 | Monsanto Company | Gellan gum tablet coating |
JP2002517568A (ja) * | 1998-06-10 | 2002-06-18 | モンサント・ピーエルシー | 改質ゲランガム組成物、その調製工程およびその用途 |
US6291506B1 (en) * | 1998-08-04 | 2001-09-18 | Wisconsin Alumni Research Foundation | Method of reducing retinal ganglion cell degeneration |
US5994363A (en) * | 1998-08-24 | 1999-11-30 | Pentech Pharmaceuticals, Inc. | Amelioration of apomorphine adverse effects |
US6552024B1 (en) * | 1999-01-21 | 2003-04-22 | Lavipharm Laboratories Inc. | Compositions and methods for mucosal delivery |
EP1480624B1 (en) * | 2002-02-07 | 2006-11-29 | Pharmacia Corporation | Pharmaceutical tablet |
-
2003
- 2003-02-06 AT AT03710927T patent/ATE340565T1/de not_active IP Right Cessation
- 2003-02-06 KR KR1020047012166A patent/KR100666520B1/ko not_active IP Right Cessation
- 2003-02-06 PT PT03710927T patent/PT1471890E/pt unknown
- 2003-02-06 RU RU2004124057/15A patent/RU2285520C2/ru not_active IP Right Cessation
- 2003-02-06 AU AU2003215110A patent/AU2003215110B2/en not_active Expired - Fee Related
- 2003-02-06 PL PL03372290A patent/PL372290A1/pl unknown
- 2003-02-06 NZ NZ534340A patent/NZ534340A/en unknown
- 2003-02-06 DK DK03710927T patent/DK1471890T3/da active
- 2003-02-06 BR BR0307473-0A patent/BR0307473A/pt not_active IP Right Cessation
- 2003-02-06 WO PCT/US2003/003836 patent/WO2003066029A2/en active IP Right Grant
- 2003-02-06 ES ES03710927T patent/ES2271542T3/es not_active Expired - Lifetime
- 2003-02-06 CN CNB038034190A patent/CN100346832C/zh not_active Expired - Fee Related
- 2003-02-06 JP JP2003565453A patent/JP2005519924A/ja active Pending
- 2003-02-06 EP EP03710927A patent/EP1471890B1/en not_active Expired - Lifetime
- 2003-02-06 CA CA002474190A patent/CA2474190A1/en not_active Abandoned
- 2003-02-06 DE DE60308647T patent/DE60308647T2/de not_active Expired - Fee Related
- 2003-02-06 US US10/360,167 patent/US20030235617A1/en not_active Abandoned
- 2003-02-06 MX MXPA04007728A patent/MXPA04007728A/es active IP Right Grant
-
2004
- 2004-07-14 ZA ZA200405614A patent/ZA200405614B/en unknown
- 2004-08-06 CO CO04076758A patent/CO5611096A2/es not_active Application Discontinuation
- 2004-09-06 NO NO20043723A patent/NO20043723L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BR0307473A (pt) | 2004-11-09 |
US20030235617A1 (en) | 2003-12-25 |
NO20043723L (no) | 2004-09-06 |
RU2004124057A (ru) | 2005-04-20 |
JP2005519924A (ja) | 2005-07-07 |
CN100346832C (zh) | 2007-11-07 |
KR20040083503A (ko) | 2004-10-02 |
RU2285520C2 (ru) | 2006-10-20 |
AU2003215110A1 (en) | 2003-09-02 |
PT1471890E (pt) | 2007-01-31 |
MXPA04007728A (es) | 2004-11-10 |
ZA200405614B (en) | 2005-06-27 |
DE60308647D1 (de) | 2006-11-09 |
WO2003066029A3 (en) | 2003-10-16 |
DE60308647T2 (de) | 2007-08-09 |
CO5611096A2 (es) | 2006-02-28 |
AU2003215110B2 (en) | 2007-11-29 |
DK1471890T3 (da) | 2007-01-08 |
ES2271542T3 (es) | 2007-04-16 |
CN1627938A (zh) | 2005-06-15 |
NZ534340A (en) | 2006-04-28 |
ATE340565T1 (de) | 2006-10-15 |
WO2003066029A2 (en) | 2003-08-14 |
KR100666520B1 (ko) | 2007-01-11 |
EP1471890B1 (en) | 2006-09-27 |
CA2474190A1 (en) | 2003-08-14 |
EP1471890A2 (en) | 2004-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL372290A1 (pl) | Farmaceutyczna postać dawkowana do podawania śluzówkowego | |
PT1419765E (pt) | Métodos de manufactura de composições farmacêuticas | |
MXPA02004235A (es) | Dosificacion de farmacos a traves de la mucosa oral usando una solucion solida. | |
WO2003047519A3 (en) | 'compressed annular tablet with molded triturate tablet for oral and intraoral' | |
WO2002067903A3 (en) | Compositions and methods of manufacture for oral dissolvable dosage forms | |
TW200505498A (en) | Sugar-free oral transmucosal solid dosage forms and uses thereof | |
WO2007012019A3 (en) | Medicaments containing famotidine and ibuprofen and administration of same | |
WO2008085765A3 (en) | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain | |
EP2248519A3 (en) | Non-mucoadhesive film dosage forms | |
JP2007523091A5 (pl) | ||
CA2066403A1 (en) | Transmucosal dosage form | |
PL2043637T3 (pl) | Sposoby i leki do podawania ibuprofenu | |
NO20071795L (no) | Octenidin-inneholdende tabletter anvendt mot betennelsessykdommer i munn og svelg | |
EP1778209B8 (en) | Methods and compositions for oral delivery of fts | |
JP2005525329A5 (pl) | ||
MXPA06000332A (es) | Nueva composicion farmaceutica solida que comprende amisulprida. | |
RU2004129284A (ru) | Амброксол для лечения болей в полости рта и глотки | |
WO2004060260A3 (en) | Drug delivery system with vented mouthpiece | |
Bhoi et al. | An Innovative approach for Oral Drug Delivery System | |
GB0224492D0 (en) | Pharmaceutical compositions of rapid drug delivery system to carry active ingredients for fast dissolving tablets by mouth administration | |
MY145885A (en) | Controlled release formulations for oral administration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |